Table 1 The characteristics of included patients
Variables | All patients (N = 564) | Non-CRPA (N = 421) | CRPA (N = 143) | p-value |
|---|---|---|---|---|
Demographics | ||||
Age (years), median (IQR) | 62.55 (52.50–70.95) | 61.50 (52.40–70.20) | 64.30 (52.80–73.60) | 0.117 |
Male | 233 (41.31%) | 168 (39.90%) | 65 (45.45%) | 0.244 |
BMI (kg/m2) | 21.49 (19.20–23.79) | 21.50 (19.11–23.83) | 21.48 (19.32–23.30) | 0.932 |
Comorbidities | ||||
Hypertension | 104 (18.44%) | 73 (17.34%) | 31 (21.68%) | 0.248 |
Diabetes | 70 (12.41%) | 46 (10.93%) | 24 (16.78%) | 0.066 |
COPD | 116 (20.57%) | 79 (18.76%) | 37 (25.87%) | 0.069 |
Malignant tumors | 36 (6.38%) | 24 (5.70%) | 12 (8.39%) | 0.255 |
Asthma | 32 (5.67%) | 20 (4.75%) | 12 (8.39%) | 0.104 |
Connected tissue disease | 23 (4.08%) | 16 (3.80%) | 7 (4.90%) | 0.567 |
Gastro-oesophageal reflux disease | 22 (3.90%) | 18 (4.28%) | 4 (2.80%) | 0.430 |
Hemoptysis | 139 (24.65%) | 106 (25.18%) | 33 (23.08%) | 0.614 |
BAE | 58 (10.28%) | 47 (11.16%) | 11 (7.69%) | 0.238 |
Antibiotic treatment | 515 (91.31%) | 389 (92.40%) | 126 (88.11%) | 0.116 |
Laboratory Values | ||||
WBC (× 10⁹/L), median (IQR) | 6.92 (5.31–8.99) | 6.75 (5.17–8.74) | 7.44 (5.84–9.90) | 0.007 |
ANC (× 10⁹/L), median (IQR) | 4.73 (3.28–6.52) | 4.44 (3.11–6.12) | 5.60 (4.04–8.13) | < 0.001 |
AEC (× 10⁹/L), median (IQR) | 0.11 (0.05–0.21) | 0.11 (0.06–0.22) | 0.09 (0.02–0.18) | 0.020 |
PLT (× 10⁹/L), median (IQR) | 201 (149.5- 263) | 199 (149–259) | 213 (154–288) | 0.152 |
Hemoglobin (g/L), median (IQR) | 118 (106–132) | 120 (109–133) | 113 (99–127) | < 0.001 |
Lengths of hospital stay, median (IQR) | 12 (9- 15.5) | 11 (9–14) | 14 (10–20) | < 0.001 |
Acute exacerbations* | 247 (43.79%) | 167 (39.67%) | 80 (55.94%) | 0.001 |